msCT-rhLeptin fusion protein for treating osteoporosis and obesity and nucleic acid encoding fusion protein

msCT-rhLeptin fusion protein for treating osteoporosis and obesity and nucleic acid encoding fusion protein

  • CN 102,964,452 A
  • Filed: 12/12/2012
  • Published: 03/13/2013
  • Est. Priority Date: 12/12/2012
  • Status: Active Application
First Claim
Patent Images

1. be used for controlling osteoporosis and fat msCT-rhLeptin fusion rotein, it is characterized in that be used to the aminoacid sequence of controlling osteoporosis and the msCT-rhLeptin fusion rotein of obesity shown in SEQ ID NO:

  • 2.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×